Literature DB >> 7684747

Rejection criteria for endotracheal aspirates from adults.

A J Morris1, D C Tanner, L B Reller.   

Abstract

Although criteria have been established to assess the quality of sputum specimens, no criteria for assessing the quality of endotracheal suction aspirates (ETSA) exist. Therefore, we compared the Gram stain (GS) and culture results for 504 consecutive ETSA specimens. Results recorded for GS included the numbers of squamous epithelial cells (SEC) and polymorphonuclear leukocytes (PML) per low-power field (LPF) (magnification, x100) as well as the quantities and types of organisms per high-power field (HPF) (magnification, x1,000). Culture results were quantitated by organism. Only 15% of ETSA specimens tested by GS contained > 10 SEC per LPF, and 21, 20, and 59% had < or = 10, 11 to 24, and > or = 25 PML per LPF, respectively. For 40% of ETSA specimens, no organisms were visible by GS. Of these specimens, 40% were sterile, 48% grew normal oropharyngeal flora (NF) only, 5% grew 1+ NF (i.e., > 10 colonies in the first quadrant) and 1+ gram-negative rods (GNR), and 7% grew < or = 1+ GNR either alone or in mixed culture. The mean numbers of organisms recovered from ETSA with < or = 10 SEC per LPF and > 10 SEC per LPF were 2.35 and 4.05, respectively. We therefore recommend that ETSA specimens that show no organisms by GS be rejected, in addition to those with > 10 SEC per LPF. Application of these rejection criteria enabled us to reject 847 (41%) of 2,068 ETSA specimens over a 6-month period. This represents a saving of approximately $66,000/year in unnecessary laboratory charges to patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7684747      PMCID: PMC262874          DOI: 10.1128/jcm.31.5.1027-1029.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  7 in total

1.  Microscopic and baceriologic analysis of expectorated sputum.

Authors:  P R Murray; J A Washington
Journal:  Mayo Clin Proc       Date:  1975-06       Impact factor: 7.616

2.  Microscopic and bacteriological comparison of paired sputa and transtracheal aspirates.

Authors:  R W Geckler; D H Gremillion; C K McAllister; C Ellenbogen
Journal:  J Clin Microbiol       Date:  1977-10       Impact factor: 5.948

3.  Bacterial sputum cultures. A clinician's viewpoint.

Authors:  R E Van Scoy
Journal:  Mayo Clin Proc       Date:  1977-01       Impact factor: 7.616

4.  Acceptability and cost savings of selective sputum microbiology in a community teaching hospital.

Authors:  H S Heineman; R R Radano
Journal:  J Clin Microbiol       Date:  1979-10       Impact factor: 5.948

5.  Changing pharyngeal bacterial flora of hospitalized patients. Emergence of gram-negative bacilli.

Authors:  W G Johanson; A K Pierce; J P Sanford
Journal:  N Engl J Med       Date:  1969-11-20       Impact factor: 91.245

6.  Assessment of expectorated sputum for bacteriological analysis based on polymorphs and squamous epithelial cells: six-month study.

Authors:  R S Martin; R K Sumarah; E M Robart
Journal:  J Clin Microbiol       Date:  1978-12       Impact factor: 5.948

Review 7.  Nosocomial pneumonia in the intubated patient.

Authors:  D E Craven; M R Driks
Journal:  Semin Respir Infect       Date:  1987-03
  7 in total
  19 in total

1.  Sampling variability in the microbiological evaluation of expectorated sputa and endotracheal aspirates.

Authors:  S Nagendra; P Bourbeau; S Brecher; M Dunne; M LaRocco; G Doern
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

2.  Pulmonary Infections in Ventilated Patients: Diagnostic and Therapeutic Options.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-06       Impact factor: 3.725

3.  Development, implementation, and impact of acceptability criteria for serologic tests for infectious diseases.

Authors:  John A Crump; Jennifer R Corder; Nancy G Henshaw; L Barth Reller
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

4.  Ventilator-associated pneumonia: diagnosis, treatment, and prevention.

Authors:  Steven M Koenig; Jonathon D Truwit
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

5.  Infectious disease physicians rate microbiology services and practices.

Authors:  E J Baron; D Francis; K M Peddecord
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

Review 6.  Detection of infection or infectious agents by use of cytologic and histologic stains.

Authors:  G L Woods; D H Walker
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

7.  Cost and time savings following introduction of rejection criteria for clinical specimens.

Authors:  A J Morris; L K Smith; S Mirrett; L B Reller
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

8.  Reproducibility of quantitative cultures of endotracheal aspirates from mechanically ventilated patients.

Authors:  D C Bergmans; M J Bonten; P W De Leeuw; E E Stobberingh
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

9.  Rejection criteria for endotracheal aspirates.

Authors:  H D Isenberg
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

Review 10.  Bronchoscopic diagnosis of pneumonia.

Authors:  V S Baselski; R G Wunderink
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.